학술논문
PIK3CA/BRAF mutations negatively affect outcome of patients with KRAS wild-type metastatic colorectal cancer treated with front line anti-EGFR monoclonal antibodies: Meta-analysis results
Document Type
Journal
Source
Subject
Language
English
ISSN
15387445